Qualifying Therapeutic Discovery Project Grants for the State of North Dakota
The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.
The project descriptions below were extracted from the applicant certification forms as submitted.
|Applicant Name||Project Name||Grants Awarded for 2009||Grants Awarded for 2010|
|Aldevron LLC||Egc Superantigens for Treatment of Stage IIIB NSCLC with Pleural Effusion||$ 52,015.00||$ 192,464.24|
|Altravax Inc||A Therapapeutic Vaccine for Treatment of Chronic Hepatitis B Infection||$ 244,479.24|
|NovaDigm Therapeutics, Inc||Vaccine against Staphylococcus aureus and Candida||$ 244,479.24|